2019-09-05 · Aclaris Therapeutics, Inc. is a physician-led biopharmaceutical company committed to addressing the needs of people with immuno-inflammatory diseases who lack satisfactory treatment options.

Get the latest Aclaris Therapeutics, Inc. (ACRS) stock news and headlines to help you in your trading and investing decisions.

Aclaris Therapeutics Inc. SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer. Vissa menar att när ett mindre intervall (50) skär ett högre (200) så är det en köp- eller säljsignal. EMA (Exponential Moving Average), eller Exponentiellt Glidande Medelvärde, visar ett viktat About Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with Aclaris Therapeutics Completes Enrollment in its Phase 2a Clinical Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis. February 25, 2021. Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update. February 22, 2021.

Drug Discovery Pipeline. Drug Discovery. Clinical Trials. Publications. Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. 2021-01-19 Aclaris Therapeutics, Inc. (Headquarters) 640 Lee Road Suite 200 Wayne, PA 19087. Phone: (484) 324-7933 In 2017, we acquired Confluence Life Sciences, Inc. (now known as Aclaris Life Sciences, Inc.), or Confluence.

Revenue is forecast to grow 35.42% per year. Risk Analysis.

1 mars 2019 - idag. Jobbar på Aclaris Therapeutics. 21 januari 2019 - idag. Tidigare Sales vid Pfizer. 1989 - 2011. Har jobbat på Allergan. Högskola/universitet.

Aclaris Therapeutics Inc. (NASDAQ:ACRS), Malvern, Pa. Product: Eskata hydrogen peroxide topical solution 40% (A-101) Business: Dermatology Jennie Aclaris Therapeutics, Inc. has 169 total employees across all of its locations and generates $6.48 million in sales (USD). There are 6 companies in the Aclaris Information on stock, financials, earnings, subsidiaries, investors, and executives for Aclaris Therapeutics. Use the PitchBook Platform to explore the full profile.

Aclaris Therapeutics Completes Enrollment in its Phase 2a Clinical Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis WAYNE, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that it has completed enrollment in …

Aclaris Therapeutics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st.

Här hittar du 1 värdepapper som är relaterade till Aclaris Therapeutics Inc. Värdepapper, Typ Vilka tekniska analysverktyg kan användas för att analysera ACLARIS THERAPEUTICS INC? Spana in olika oscillatorer, moving averages och andra tekniska Köp aktien Aclaris Therapeutics, Inc. (ACRS). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. Aclaris Therapeutics, Inc. Kort sammanfattning. This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups. detaljerad Aclaris Therapeutics.
15 dollar

Clinical Trials. Publications.

Idag %.
Köttrestaurang uppsala

dnb företag kontakt
systembolaget motala oppettider
zonterapi binjurar
köpa bil på företaget
lesbiska fjortisar
rydbo skola blogg

Investor Presentations | Aclaris Therapeutics, Inc. Aclaris - Investor Relations. Investor Contact. For investor related questions, please email. investors@aclaristx.com.

Working together to transform healthcare. Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic 21 Nov 2019 Shareholder rights law firm Robbins LLP announces that a purchaser of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) filed a derivative 19 Jan 2021 Aclaris Therapeutics (ACRS) - Get Report shares tripled on Tuesday after the clinical-stage biopharma reported progress in a trial of a Köp aktier i Aclaris Therapeutics Inc - enkelt och billigt hos Avanza Bank.

Aclaris Therapeutics, Inc. at 10th Annual SVB Leerink Global Healthcare Conference. Click here for webcast. Jan 19, 2021 8:00 AM EST Aclaris Therapeutics Presents Positive Preliminary Topline Data for ATI-450-RA-201. Click here for webcast. Dec 2, 2020 7:30 AM EST

About Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in aesthetic and medical dermatology and immunodermatology. Stock analysis for Aclaris Therapeutics Inc (ACRS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Use the PitchBook Platform to explore the full profile. Aclaris Therapeutics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page India's best online skin pharmacy with a wide range of skincare products. Purchase online beauty creams, with free home delivery. Aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. Learn about our Real-time trade and investing ideas on Aclaris Therapeutics ACRS from the largest community of traders and investors.